Home GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb
 

Keywords :   


GlaxoSmithKline Pharma loses patent claim on breast cancer drug Tykerb

2013-08-02 16:15:06| Biotech - Topix.net

The Intellectual Property Appellate Board has revoked the patent granted to the British drug major Glaxosmithkline Pharma Ltd for its breast cancer drug - Tykerb.

Tags: drug claim cancer patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07X-Rite wins PRINTING United Alliance 2024 Pinnacle Product Award
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Pixalate releases Latin America CTV SSP market share rankings
01.07Hurricane Beryl Graphics
01.07Pixalate releases North America CTV SSP market share rankings
01.07Hurricane Beryl Forecast Discussion Number 12
01.07Hurricane Beryl Wind Speed Probabilities Number 12
More »